Trivitas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 272,251 | 276,308 | 382,555 | 396,779 | 412,324 | 441,229 | 682,348 | 423,280 |
| Profit before tax | 23,937 | - | 23,370 | 13,142 | 19,610 | 15,476 | 45,576 | 5,761 |
| Net profit | 22,670 | 7,878 | 19,683 | 10,341 | 16,219 | 12,998 | 39,102 | 4,949 |
| Equity | 92,246 | 100,124 | 119,829 | 130,169 | 146,451 | 159,449 | 203,068 | 203,963 |
| Liabilities | 86,524 | 112,028 | 98,458 | 85,184 | 73,728 | 68,520 | 54,833 | 48,208 |
| Non-current assets | 98,048 | 97,863 | 93,185 | 94,807 | 79,138 | 62,189 | 78,648 | 69,877 |
| Current assets | 80,397 | 114,289 | 124,498 | 119,606 | 140,613 | 165,780 | 178,927 | 182,294 |
| Total assets | 178,445 | 212,152 | 217,683 | 214,413 | 219,751 | 227,969 | 257,575 | 252,171 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 33,444 | 36,955 | 37,444 |
| Social insurance contributions | - | - | - | - | - | 17,381 | 18,896 | 20,731 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +11.8% | +1.5% | +38.5% | +3.7% | +3.9% | +7.0% | +54.6% | -38.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.7% | 3.7% | 9.0% | 4.8% | 7.4% | 5.7% | 15.2% | 2.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 24.6% | 7.9% | 16.4% | 7.9% | 11.1% | 8.2% | 19.3% | 2.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.3% | 2.9% | 5.1% | 2.6% | 3.9% | 2.9% | 5.7% | 1.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.8% | - | 6.1% | 3.3% | 4.8% | 3.5% | 6.7% | 1.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 1.1 | 0.8 | 0.7 | 0.5 | 0.4 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 38,893 | 35,274 | 47,819 | 49,597 | 51,541 | 55,154 | 85,294 | 52,910 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Trivitas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-12-18 | 2023-12-19 | 0.01 |
| 2023-11-16 | 2023-12-12 | 0.01 |
| 2023-10-17 | 2023-11-13 | 0.01 |
| 2023-09-18 | 2023-10-11 | 0.01 |
| 2023-08-17 | 2023-09-13 | 0.01 |
| 2023-07-24 | 2023-08-13 | 0.01 |
| 2021-11-16 | 2021-12-13 | 0.01 |
Trivitas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-03 | 2025-10-18 | 29.93 |
| 2025-09-28 | 2025-10-02 | 0.01 |
| 2025-09-19 | 2025-09-23 | 0.01 |
| 2025-02-20 | 2025-02-24 | 0.01 |
| 2025-01-24 | 2025-01-27 | 273.54 |
| 2025-01-15 | 2025-01-15 | 87.3 |
| 2025-01-14 | 2025-01-14 | 121.59 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Trivitas, UAB (code 184076752) is a private limited liability company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €423.3K, down 38.0% year on year and 4.1% below the 2023 level of €441.2K. Profitability weakened more sharply than sales: net profit fell from €13.0K in 2023 to €39.1K in 2024, then declined to €4.9K in 2025, with the net profit margin easing to 1.2% from 5.7% in 2024. The balance sheet remained solid, with total assets of €252.2K, equity of €204.0K and liabilities of €48.2K at the end of 2025. Long-term assets stood at €69.9K and short-term assets at €182.3K. Key ratios indicate a stable capital structure, including an equity ratio of 80.9%, debt-to-equity of 0.24 and asset turnover of 1.68x. Return on equity was 2.4% and return on assets 2.0%. Revenue per employee was €52.9K, while profit per employee was €619.